Surgical treatment of recurrent endometrial cancer with a pelvic abscess: a clinical case

The article presents a clinical case of a patient with stage IA endometrial cancer, who, at a later date following specialized treatment conducted according to established standards, was diagnosed with disease progression complicated by an abscess in the pelvic area. The treatment strategy involved radical surgical intervention, which included pelvic sanitation, abscess resolution, and simultaneous complete cytoreduction – resection of the sigmoid colon, ureteral ligation, creation of a single-barrel colostomy, and extended pelvic lymphadenectomy. A key factor in implementing the treatment plan was an interdisciplinary approach involving specialists from various fields to address both the oncological process and the resulting complications, which led to the effectiveness of the procedures performed.

1. International Agency for Research on Cancer. GLOBOCAN 2022: Estimated Cancer Incidence, Mortality and Prevalence Worldwide. World Health Organization, 2023.

2. The state of oncological care for the population of Russia in 2023. Edited by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2024. 262 p. (In Russ.).

3. Uterine body cancer and uterine sarcomas: Clinical guidelines. Moscow: Ministry of Health of Russia, 2022. Available at: https://cr.minzdrav.gov.ru/recomend/460_3. (In Russ.).

4. Oaknin A., Bosse T.J., Creutzberg C.L. et al. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022;33(9):860–77. DOI: 10.1016/j.annonc.2022.05.009

5. Abu-Rustum N., Yashar C., Arend R. et al. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2023;21(2):181–209. DOI: 10.6004/jnccn.2023.000

6. Concin N., Matias-Guiu X., Vergote I. et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021;31(1):12–39. DOI: 10.1136/ijgc-2020-002230

7. Crosbie E.J., Kitson S.J., McAlpine J.N. et al. Endometrial cancer. Lancet 2022;399(10333):1412–28. DOI: 10.1016/S0140-6736(22)00323-3

8. Lavie O., Uriev L., Gdalevich M. et al. The outcome of patients with stage I endometrial cancer involving the lower uterine segment. Int J Gynecol Cancer 2008;18:1079–83. DOI: 10.1111/j.1525-1438.2007.01150.x

9. Kizer N.T., Gao F., Guntupalli S. et al. Lower uterine segment involvement is associated with poor outcomes in early-stage endometrioid endometrial carcinoma. Ann Surg Oncol 2011;18:1419–24. DOI: 10.1245/s10434-010-1454-9

10. Davidesko S., Meirovitz M., Shaco-Levy R. et al. The significance of lower uterine segment involvement in endometrial cancer. Eur J Surg Oncol 2024;50(3):108007. DOI: 10.1016/j.ejso.2024.108007

11. Madom L.M., Brown A.K., Lui F. et al. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma. Gynecol Oncol 2007;107(1):75–8.

12. Doll K.M., Tseng J., Denslow S.A. et al. High-grade endometrial cancer: Revisiting the impact of tumor size and location on outcomes. Gynecol Oncol 2014;132(1):44–9. DOI: 10.1016/j.ygyno.2013.10.023

13. Erkaya S., Öz M., Topçu H.O. et al. Is lower uterine segment involvement a prognostic factor in endometrial cancer? Turk J Med Sci 2017;47(1):300–6. DOI: 10.3906/sag-1602-137

14. Miyoshi A., Kanao S., Naoi H. et al. Investigation of the clinical features of lower uterine segment carcinoma: Association with advanced stage disease and indication of poorer prognosis. Arch Gynecol Obstet 2018;297:193–8. DOI: 10.1007/s00404-017-4576-5

15. Morkhov K.Yu., Kreynina Yu.M., Pokataev I.A., Nechushkina V.M. Interdisciplinary approach to the management of patients with progression of uterine cancer. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of Female Reproductive System 2022;18(1):87–96. (In Russ.). DOI: 10.17650/1994-4098-2022-18-1-87-96

16. Fix N., Classen-von Spee S., Baransi S. et al. Pelvic exenteration for recurrent endometrial cancer: A 15-year monocentric retrospective study. Cancers 2023;15(19):4725. DOI: 10.3390/cancers15194725

17. Morris M., Eifel P.J., Lu J. et al. Pelvic exenteration: Factors associated with major surgical morbidity and disease control. Gynecol Oncol 1996;62(3):356–61. DOI: 10.1006/gyno.1996.0242

18. Serban D., Stefan D.-C., Simion L. Pelvic exenteration in advanced, recurrent or synchronous cancers – last resort or therapeutic option? Diagnostics 2024;14(16):1707. DOI: 10.3390/diagnostics14161707

19.